The Effect of Hepatic Impairment on the Pharmacokinetics of Balovaptan

Stopped The study is on hold due to stopping of the Autism Spectrum Disorder program with balovatpan, the study drug.

Conditions

• Autism Spectrum Disorder

Interventions

• DRUG: Balovaptan

Sponsor

Hoffmann-La Roche